Table 5 MRI characteristics of study population adjusted for BMI, SBP, DBP and medicine treatment
|  | T2DM (n = 27) | T2DM-HT (n = 23) | Control (n = 31) | P value |
|---|---|---|---|---|
LVEDV index (mL/m2) | 57.5 ± 3.1 | 68.4 ± 5.5 | 61.8 ± 3.5 | 0.230 |
LVESV index (mL/m2) | 26.1 ± 1.6 | 34.1 ± 2.9 | 25.3 ± 1.8 | 0.104 |
SV | 33.5 ± 1.4 | 35.8 ± 2.5 | 35.5 ± 1.6 | 0.512 |
LVEF (%) | 55.7 ± 1.1 | 57.9 ± 2.0 | 58.3 ± 1.3 | 0.223 |
LVM index (g/m2) | 56.3 ± 1.7 | 57.7 ± 3.0 | 56.0 ± 1.9 | 0.920 |
LAV index (mL/m2) | 39.5 ± 2.3 | 32.0 ± 4.2 | 38.9 ± 2.7 | 0.394 |
LVGRS (%) | 83.1 ± 5.7 | 84.2 ± 10.1 | 80.1 ± 6.5 | 0.926 |
LVGCS (%) | −20.8 ± 0.8 | −20.5 ± 1.4 | −21.5 ± 0.9 | 0.794 |
LVGLS (%) | −22.0 ± 0.8 | −22.9 ± 1.5 | −21.6 ± 1.0 | 0.853 |
LAGRS (%) | −28.6 ± 1.1*# | −36.8 ± 2.0 | −31.9 ± 1.3 | 0.003 |
LAGCS (%) | 27.2 ± 2.1*# | 40.4 ± 3.8$ | 33.5 ± 2.4 | 0.008 |
LAGLS (%) | 24.3 ± 1.3*# | 32.3 ± 2.4 | 31.4 ± 1.5 | <0.001 |
RVGLS (%) | −21.4 ± 1.2# | −21.4 ± 1.4$ | −26.3 ± 1.1 | 0.008 |